• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫铆素 - 磷脂复合物的制备、表征及评价

Preparation, characterization and evaluation of Marsupsin-phospholipid complex.

作者信息

Sikarwar Mukesh S, Sharma Shalini, Jain Amit K, Parial S D

机构信息

Department of Pharmacognosy and Phytochemistry, B. R. Nahata College of Pharmacy, Mhow-Neemuch Road, Mandsaur 458001, India.

出版信息

AAPS PharmSciTech. 2008;9(1):129-37. doi: 10.1208/s12249-007-9020-x. Epub 2008 Jan 18.

DOI:10.1208/s12249-007-9020-x
PMID:18446473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2976887/
Abstract

The aim of this research was to formulate Marsupsin-phospholipid complex (M-P Complex) in attempt to increase the bioavailability of marsupsin and to characterize this new formulation along with its evaluation. Marsupsin-phospholipid complex was formulated by mechanical dispersion method. In this new formulation, complex formation was confirmed by carrying out transmission electron microscopy (TEM), IR, (1)H-NMR and RP-HPLC analysis. TEM showed M-P Complex diameter range of 0.05-0.5 microm. The entrapment efficiency of M-P Complex was found to be 44%. In vitro release study revealed its first order release profile. Mean blood serum concentration vs time curve of marsupsin was of first order after oral administration of M-P Complex in albino rabbits which clearly showed remarkably increased bioavailability of M-P Complex than standardized marsupsin. The average value of C(max) and T(max) of M-P Complex were found to be 3.02 mg/ml and 10.2 h, respectively. Hence the findings demonstrate that complexing marsupsin with phospholipids results in better oral bioavailability and improved biological response than free form of standardized marsupsin.

摘要

本研究的目的是制备紫铆素 - 磷脂复合物(M - P复合物),以提高紫铆素的生物利用度,并对这种新制剂进行表征和评估。采用机械分散法制备紫铆素 - 磷脂复合物。在这种新制剂中,通过透射电子显微镜(TEM)、红外光谱(IR)、氢核磁共振(¹H - NMR)和反相高效液相色谱(RP - HPLC)分析确认了复合物的形成。TEM显示M - P复合物的直径范围为0.05 - 0.5微米。发现M - P复合物的包封率为44%。体外释放研究显示其符合一级释放曲线。在白化兔口服M - P复合物后,紫铆素的平均血清浓度与时间曲线呈一级,这清楚地表明M - P复合物的生物利用度比标准紫铆素显著提高。M - P复合物的C(max)和T(max)平均值分别为3.02毫克/毫升和10.2小时。因此,研究结果表明,与游离形式的标准紫铆素相比,紫铆素与磷脂形成复合物可导致更好的口服生物利用度和改善的生物学反应。

相似文献

1
Preparation, characterization and evaluation of Marsupsin-phospholipid complex.紫铆素 - 磷脂复合物的制备、表征及评价
AAPS PharmSciTech. 2008;9(1):129-37. doi: 10.1208/s12249-007-9020-x. Epub 2008 Jan 18.
2
Process optimization, characterization and pharmacokinetic evaluation in rats of ursodeoxycholic acid-phospholipid complex.熊去氧胆酸-磷脂复合物在大鼠体内的工艺优化、表征及药代动力学评价
AAPS PharmSciTech. 2008;9(1):322-9. doi: 10.1208/s12249-008-9040-1. Epub 2008 Feb 7.
3
Preparation, characterization, and bioavailability of ursodeoxycholic acid-phospholipid complex in vivo.熊去氧胆酸-磷脂复合物的体内制备、表征及生物利用度
Drug Dev Ind Pharm. 2008 Jul;34(7):708-18. doi: 10.1080/03639040701842477.
4
The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.水飞蓟宾-磷脂复合物的制备及其在大鼠体内的药代动力学研究。
Int J Pharm. 2006 Jan 3;307(1):77-82. doi: 10.1016/j.ijpharm.2005.10.001. Epub 2005 Nov 18.
5
Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation.用于口服胰岛素递送的自组装卵磷脂/壳聚糖纳米颗粒:制备与功能评价
Int J Nanomedicine. 2016 Feb 24;11:761-9. doi: 10.2147/IJN.S96146. eCollection 2016.
6
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.负载胰岛素-磷脂复合物的可生物降解纳米颗粒用于口服给药:制备、体外表征及体内评价
J Control Release. 2006 Aug 28;114(2):242-50. doi: 10.1016/j.jconrel.2006.05.013. Epub 2006 May 24.
7
Biodegradable anionic acrylic resin based hollow microspheres of moderately water soluble drug rosiglitazone maleate: preparation and in vitro characterization.基于可生物降解阴离子型丙烯酸树脂的马来酸罗格列酮中空微球的制备及体外特性研究。
Drug Dev Ind Pharm. 2012 Dec;38(12):1460-9. doi: 10.3109/03639045.2011.653811. Epub 2012 Feb 23.
8
Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo evaluation.格列齐特黏膜黏附微胶囊的设计与开发:体外和体内评价
AAPS PharmSciTech. 2008;9(1):224-30. doi: 10.1208/s12249-008-9041-0. Epub 2008 Feb 7.
9
Development and characterization of nanoparticles of glibenclamide by solvent displacement method.通过溶剂置换法制备格列本脲纳米颗粒及其表征
Acta Pol Pharm. 2010 May-Jun;67(3):283-90.
10
Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide.富含磷脂复合物的胶束:一种促进瑞格列奈抗糖尿病作用的新型药物递送方法。
Eur J Pharm Sci. 2017 Mar 1;99:75-84. doi: 10.1016/j.ejps.2016.12.005. Epub 2016 Dec 18.

引用本文的文献

1
Demystifying the Potential of Embelin-Loaded Nanoformulations: a Comprehensive Review.解析榄香素载药纳米制剂的潜力:全面综述。
AAPS PharmSciTech. 2024 Oct 21;25(8):249. doi: 10.1208/s12249-024-02968-7.
2
Phospholipid Complex Formulation Technology for Improved Drug Delivery in Oncological Settings: a Comprehensive Review.磷脂复合物制剂技术在肿瘤治疗中的药物递送改善作用:全面综述。
AAPS PharmSciTech. 2024 Apr 25;25(5):91. doi: 10.1208/s12249-024-02813-x.
3
Drug complexes: Perspective from Academic Research and Pharmaceutical Market.药物复合物:学术研究和医药市场的视角。
Pharm Res. 2023 Jun;40(6):1519-1540. doi: 10.1007/s11095-023-03517-w. Epub 2023 May 3.
4
Cationic biopolymer decorated Asiatic Acid and extract incorporated liposomes for treating early-stage Alzheimer's disease: An and investigation.载阳离子生物聚合物的熊果酸和 提取物的脂质体治疗早期阿尔茨海默病的体内和体外研究。
F1000Res. 2022 Dec 19;11:1535. doi: 10.12688/f1000research.128874.1. eCollection 2022.
5
Solvent Free Twin Screw Processed Silybin Nanophytophospholipid: In Silico, In Vitro and In Vivo Insights.无溶剂双螺杆加工水飞蓟宾纳米植物磷脂:计算机模拟、体外及体内研究洞察
Pharmaceutics. 2022 Dec 6;14(12):2729. doi: 10.3390/pharmaceutics14122729.
6
Phytosomes as Innovative Delivery Systems for Phytochemicals: A Comprehensive Review of Literature.植物药质体作为植物化学物质的创新型给药系统:文献综述。
Int J Nanomedicine. 2021 Oct 15;16:6983-7022. doi: 10.2147/IJN.S318416. eCollection 2021.
7
Phytophospholipid Complex of Caffeic Acid: Development, In vitro Characterization, and In Vivo Investigation of Antihyperlipidemic and Hepatoprotective Action in Rats.咖啡酸植物磷酯复合物:制剂开发、体外特性鉴定及在大鼠体内抗高血脂和保肝作用的研究。
AAPS PharmSciTech. 2021 Jan 6;22(1):28. doi: 10.1208/s12249-020-01887-7.
8
Phospholipid Complex Technique for Superior Bioavailability of Phytoconstituents.用于提高植物成分生物利用度的磷脂复合物技术
Adv Pharm Bull. 2017 Apr;7(1):35-42. doi: 10.15171/apb.2017.005. Epub 2017 Apr 13.
9
Preparation and Evaluation of Phospholipid-Based Complex of Standardized Centella Extract (SCE) for the Enhanced Delivery of Phytoconstituents.用于增强植物成分递送的标准化积雪草提取物(SCE)磷脂基复合物的制备与评价
AAPS J. 2016 Jan;18(1):102-14. doi: 10.1208/s12248-015-9837-2. Epub 2015 Nov 12.
10
Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability.新型吴茱萸碱-磷脂复合物的设计与评价:改善口服生物利用度。
AAPS PharmSciTech. 2012 Jun;13(2):534-47. doi: 10.1208/s12249-012-9772-9. Epub 2012 Mar 28.

本文引用的文献

1
The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.水飞蓟宾-磷脂复合物的制备及其在大鼠体内的药代动力学研究。
Int J Pharm. 2006 Jan 3;307(1):77-82. doi: 10.1016/j.ijpharm.2005.10.001. Epub 2005 Nov 18.
2
Structural investigations on lipid nanoparticles containing high amounts of lecithin.对含有大量卵磷脂的脂质纳米颗粒的结构研究。
Eur J Pharm Sci. 2006 Feb;27(2-3):226-36. doi: 10.1016/j.ejps.2005.10.004. Epub 2005 Nov 17.
3
Analysis of the active components of silymarin.水飞蓟素活性成分分析
J Chromatogr A. 2003 Mar 21;990(1-2):239-45. doi: 10.1016/s0021-9673(02)01971-4.
4
Antihyperglycemic and hypoglycemic effect of Aporosa lindleyana in normal and alloxan induced diabetic rats.岭南山竹子对正常及四氧嘧啶诱导的糖尿病大鼠的降血糖和低血糖作用。
J Ethnopharmacol. 2003 Feb;84(2-3):247-9. doi: 10.1016/s0378-8741(02)00328-8.
5
Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles.超细壳聚糖纳米粒的制备、表征及生物分布
Int J Pharm. 2002 Aug 28;243(1-2):93-105. doi: 10.1016/s0378-5173(02)00267-3.
6
High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes.超氧化物歧化酶高效包封于黏膜黏附性壳聚糖包被脂质体中。
Eur J Pharm Sci. 2002 Jun;15(5):441-8. doi: 10.1016/s0928-0987(02)00030-1.
7
Niosomes as carriers for tretinoin. I. Preparation and properties.尼奥斯体作为维甲酸的载体。I. 制备与性质。
Int J Pharm. 2002 Mar 2;234(1-2):237-48. doi: 10.1016/s0378-5173(01)00971-1.
8
An HPTLC method for the determination and the purity control of ciprofloxacin HCl in coated tablets.一种用于测定包衣片中盐酸环丙沙星并控制其纯度的高效薄层色谱法。
J Pharm Biomed Anal. 2001 Jul;25(5-6):957-64. doi: 10.1016/s0731-7085(01)00387-9.
9
Hypoglycaemic and antihyperglycaemic effects of Trigonella foenum-graecum leaf in normal and alloxan induced diabetic rats.胡芦巴叶对正常及四氧嘧啶诱导的糖尿病大鼠的降血糖和抗高血糖作用
J Ethnopharmacol. 1997 Nov;58(3):149-55. doi: 10.1016/s0378-8741(97)00101-3.
10
Antihyperglycemic activity of phenolics from Pterocarpus marsupium.紫檀酚类物质的降血糖活性
J Nat Prod. 1997 Jun;60(6):609-10. doi: 10.1021/np9607013.